BioDelivery Sciences International, Inc. (BDSI) is a specialty pharmaceutical company which develops and commercializes products in the areas of addiction medicine and pain management. The company’s marketed products include fentanyl soluble solution for breakthrough cancer pain; buprenorphine/naloxone buccal film for opioid dependence; and buprenorphine HCL buccal film for chronic pain. Its pipeline encompasses indications targeted at the treatment of cancer pain, opioid dependence, painful diabetic neuropathy, and chronic pain. BDSI employs its proprietary BioErodible MucoAdhesive (BEMA) technology which comprises small, bioerodible polymer film that facilitates rapid delivery a drug across the mucous membranes for time sensitive conditions. The company uses BEMA technology and other technologies for developing and commercializing its products. BDSI is headquartered in Raleigh, North Carolina, the US.
BioDelivery Sciences International, Inc. (BDSI) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company's operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy:
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
Summary Population Diagnostics Inc (Population Diagnostics) is a biotechnology company that carries out the research, development and discovery of platform technology for validation of causative genetic biomarkers. The company develops various therapeutic areas such as novel targeted drugs, drug rescue of Phase II & III failures,...
Summary BioCrea GmbH (BioCrea) is a healthcare company that offers drug discovery services. The company discovers and develops drugs to treat debilitating central nervous system diseases. It provides pipeline product PDE10, an inhibitor to treat Schizophrenia and Huntington’s disease. BioCrea offers discovery platforms such as...
Summary Advanced Technology Ventures (ATV) is a financial service provider that provides early stage investments in emerging growth companies and business development. The company operates on three core technology markets that include IT, healthcare and clean technology. Its healthcare services include next-generation biologics,...
Zogenix Inc (Zogenix) is a pharmaceutical company that develops and commercializes injectable therapies and delivery systems for treating central nervous system disorders and pain. The company’s product portfolio includes Zohydro ER, Sumavel DosePro and undisclosed dosepro CNS product candidate. Its pipeline products include...
Summary LineaGen Inc (LineaGen), formerly GenData Research Corporation is a healthcare services provider that includes diagnostic service. The company provides diagnostic evaluation services for complex diseases. Its offers testing services such as FirstStepDx PLUS chromosomal micro array which detect deletions and duplication...
Summary Res-Care Inc (ResCare) is one of the largest home care companies and providers of services to people with disabilities. Its major services include daily personal care assistance; closed-door pharmacy related services; homemaking services; care management; skilled nursing / therapy; neuro therapy; live-in care and overnight...
Summary Naurex Inc (Naurex) is a clinical stage biopharmaceutical company that discovers and develops compounds that modulate the NMDA receptor. The company also develops new therapies for central nervous system diseases by modulating neuronal plasticity. It is developing an adjunctive therapy for depressive disorder in patients...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.